Literature DB >> 28446543

Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.

Staci L Sudenga1, B Nelson Torres2, Roberto Silva3, Luisa L Villa4, Eduardo Lazcano-Ponce5, Martha Abrahamsen2, Maria Luiza Baggio4, Jorge Salmeron5, Manuel Quiterio5, Anna R Giuliano6.   

Abstract

Background: Male genital human papillomavirus (HPV) prevalence and incidence has been reported to vary by geographical location. Our objective was to assess the natural history of genital HPV by country among men with a median of 48 months of follow-up.
Methods: Men ages 18-70 years were recruited from United States (n = 1,326), Mexico (n = 1,349), and Brazil (n = 1,410). Genital specimens were collected every 6 months and HPV genotyping identified 37 HPV genotypes. Prevalence of HPV was compared between the three countries using the Fisher exact test. Incidence rates and 95% confidence intervals were calculated. The median time to HPV clearance among men with an incident infection was estimated using the Kaplan-Meier method.
Results: The prevalence and incidence of the genital HPV types known to cause disease in males (HPV 16 and 6) was significantly higher among men from Brazil than men from Mexico. Prevalence and incidence of those genital HPV types in the United States varied between being comparable with those of Mexico or Brazil. Although genital HPV16 duration was significantly longer in Brazil (P = 0.04) compared with Mexico and the United States, HPV6 duration was shortest in Brazil (P = 0.03) compared with Mexico and the United States.Conclusions: Men in Brazil and Mexico often have similar, if not higher prevalence of HPV compared with men from the United States.Impact: Currently, there is no routine screening for genital HPV among males and while HPV is common in men, and most naturally clear the infection, a proportion of men do develop HPV-related diseases. Men may benefit from gender-neutral vaccine policies. Cancer Epidemiol Biomarkers Prev; 26(7); 1043-52. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28446543      PMCID: PMC5556383          DOI: 10.1158/1055-9965.EPI-17-0040

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.

Authors:  U Wieland; S Jurk; S Weissenborn; T Krieg; H Pfister; A Ritzkowsky
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

2.  Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome.

Authors:  Rosa S Djajadiningrat; Ekaterina S Jordanova; Bin K Kroon; Erik van Werkhoven; Jeroen de Jong; Divera T M Pronk; Peter J F Snijders; Simon Horenblas; Daniëlle A M Heideman
Journal:  J Urol       Date:  2014-08-21       Impact factor: 7.450

3.  Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Authors:  Staci L Sudenga; B Nelson Torres; William J Fulp; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Donna J Ingles; Mark Stoler; Jane L Messina; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano
Journal:  Int J Cancer       Date:  2016-10-20       Impact factor: 7.396

Review 4.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

Review 5.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

6.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 7.  Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

Authors:  Charles J N Lacey; Catherine M Lowndes; Keerti V Shah
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

8.  The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Authors:  Anna R Giuliano; Eduardo Lazcano-Ponce; Luisa L Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary R Papenfuss; Martha Abrahamsen; Emily Jolles; Carrie M Nielson; Maria Luisa Baggio; Roberto Silva; Manuel Quiterio
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

9.  Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

Authors:  Anna R Giuliano; Beibei Lu; Carrie M Nielson; Roberto Flores; Mary R Papenfuss; Ji-Hyun Lee; Martha Abrahamsen; Robin B Harris
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

View more
  8 in total

1.  Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study.

Authors:  Emily M Nunes; Rossana V M López; Staci L Sudenga; Tarik Gheit; Massimo Tommasino; Maria L Baggio; Silvaneide Ferreira; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  Virology       Date:  2017-07-11       Impact factor: 3.616

2.  Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Authors:  Rayleen M Lewis; Lauri E Markowitz; Julia W Gargano; Martin Steinau; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

Review 3.  Multiple pathogens and prostate cancer.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Infect Agent Cancer       Date:  2022-05-30       Impact factor: 3.698

4.  Natural History of Anal Papillomavirus Infection in HIV-Negative Men Who Have Sex With Men Based on a Markov Model: A 5-Year Prospective Cohort Study.

Authors:  Zewen Zhang; Xi Ling; Lirong Liu; Miaomiao Xi; Guozhen Zhang; Jianghong Dai
Journal:  Front Public Health       Date:  2022-05-11

5.  Estimating incidence rates of grouped HPV types: A systematic review and comparison of the impact of different epidemiological assumptions.

Authors:  Vita W Jongen; Daniëla K van Santen; Catharina J Alberts; Maarten F Schim van der Loeff
Journal:  Papillomavirus Res       Date:  2019-10-07

6.  The Prevalence of HPV Genotypes in Iranian Population: An Update.

Authors:  Mina Mobini Kesheh; Hossein Keyvani
Journal:  Iran J Pathol       Date:  2019

7.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

8.  Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019.

Authors:  Xiaoxiao Li; Fenfen Xiang; Zixi Chen; Tao Zhang; Zhaowei Zhu; Mengzhe Zhang; Rong Wu; Xiangdong Kang
Journal:  Med Sci Monit       Date:  2021-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.